How blood group markers relate to blood clots
Part of Heart & circulation clinical trials.
This study looks at how certain genetic markers (Lewis antigens) on your blood cells may be linked to developing blood clots. By joining, you help researchers understand if these markers could predict clot risk, which might lead to better prevention in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 78 years old.
- You have had a blood clot in your leg (deep vein thrombosis) or in your lungs (pulmonary embolism).
- You are not currently pregnant and have not given birth within the last 6 weeks.
- You do not have liver disease or cirrhosis (scarring of the liver).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
This study looks at genetic (inherited DNA) markers in people who have had a lung blood clot (pulmonary embolism) after having a hip or knee replacement. The goal is to understand why blood clots may happen again and help improve future risk prediction and care.
This study looks at whether a specific kind of blood-cell change (“clonal hematopoiesis”) is linked to a lung blood clot (pulmonary embolism) that happened without a clear trigger. It compares people with unprovoked clots to people with provoked clots, after checking for inherited clotting risk factors.
Hear when a new Thromboembolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.